菊福堂生物控股有限公司（股票代码：08217）于2026年7月6日发布的6月股份变动月报表显示，截至2026年6月30日，公司股本保持稳定，未发生新增发行、回购或注销等变动。
公司法定股本为5亿股，每股面值0.16港元，合计8,000万港元，报告期内保持不变。已发行股份总数期初和期末均为3.0186亿股，其中普通股无新增或减少。公司当月亦无库存股，持股比例满足香港联交所的公众持股量要求。
在期权方面，公司于现有股份期权计划下分别授出了10,698,480股与9,144,000股的期权。报告期内上述期权无行使，无新股发行或库藏股份转让。
公司确认其当月的所有股份事项均符合香港联交所《上市规则》等相关法律法规要求。公告由公司秘书谭美珠签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.